{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:13:16Z","timestamp":1792725196605,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s00105-007-1327-8","type":"journal-article","created":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T12:08:25Z","timestamp":1176984505000},"page":"445-459","source":"Crossref","is-referenced-by-count":16,"title":["Kutane Leishmaniasis","Cutaneous leishmaniasis"],"prefix":"10.1007","volume":"58","author":[{"given":"E.","family":"von Stebut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sunderk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1327_CR1","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","volume":"346","author":"Alrajhi","year":"2002","unstructured":"Alrajhi AA, Ibrahim EA, De Vol EB et al. (2002) Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major. N Engl J Med 346: 891\u2013895","journal-title":"N Engl J Med"},{"key":"1327_CR2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","volume":"31","author":"Asilian","year":"2006","unstructured":"Asilian A, Davami M (2006) Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 31: 634\u2013637","journal-title":"Clin Exp Dermatol"},{"key":"1327_CR3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.0105-2896.2006.00409.x","volume":"212","author":"Belkaid","year":"2006","unstructured":"Belkaid Y, Blank RB, Suffia I (2006) Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol Rev 212: 287\u2013300","journal-title":"Immunol Rev"},{"key":"1327_CR4","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/00002030-199910010-00015","volume":"13","author":"Berhe","year":"1999","unstructured":"Berhe N, Wolday D, Hailu A et al. (1999) HIV viral load and response to antileishmanial chemotherapy in co-infected patients. Aids 13: 1921\u20131925","journal-title":"Aids"},{"key":"1327_CR5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.6.8.1381","volume":"6","author":"Berman","year":"2005","unstructured":"Berman J (2005) Miltefosine to treat leishmaniasis. Expert Opin Pharmacother 6: 1381\u20131388","journal-title":"Expert Opin Pharmacother"},{"key":"1327_CR6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","volume":"53","author":"Blum","year":"2004","unstructured":"Blum J, Desjeux P, Schwartz E et al. (2004) Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother 53: 158\u2013166","journal-title":"J Antimicrob Chemother"},{"key":"1327_CR7","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/IAI.69.5.3232-3239.2001","volume":"69","author":"Bottrel","year":"2001","unstructured":"Bottrel R, Dutra W, Martins F et al. (2001) Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis. Infect Immun 69: 3232\u20133239","journal-title":"Infect Immun"},{"key":"1327_CR8","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1128\/IAI.71.4.2244-2246.2003","volume":"71","author":"Bourreau","year":"2003","unstructured":"Bourreau E, Gardon J, Pradinaud R et al. (2003) The responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses. Infect Immun 71: 2244\u20132246","journal-title":"Infect Immun"},{"key":"1327_CR9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/502980","volume":"193","author":"Campanelli","year":"2006","unstructured":"Campanelli AP, Roselino AM, Cavassani KA et al. (2006) CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis 193: 1313\u20131322","journal-title":"J Infect Dis"},{"key":"1327_CR10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","volume":"95","author":"Desjeux","year":"2001","unstructured":"Desjeux, P (2001) The increase risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239\u2013243","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1327_CR11","unstructured":"El-On J, Bazarsky E, Sneir R (in press) Leishmania major: In vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod. Exp Parasitol 30: Epub ahead of print"},{"key":"1327_CR12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0035-9203(93)90441-R","volume":"87","author":"Gradoni","year":"1993","unstructured":"Gradoni L, Scalone A, Gramoccia M (1993) HIV-Leishmania co-infections in Italy: serological data as an indication of the sequence of acquisition of the two infections. Trans R Soc Trop Med Hyg 87: 94\u201396","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1327_CR13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0190-9622(96)80121-6","volume":"34","author":"Grevelink","year":"1996","unstructured":"Grevelink SA, Lerner EA (1996) Leishmaniasis. J Am Acad Dermatol 34: 257\u2013272","journal-title":"J Am Acad Dermatol"},{"key":"1327_CR14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","volume":"166","author":"Kane","year":"2001","unstructured":"Kane MM, Mosser DM (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166: 1141\u20131147","journal-title":"J Immunol"},{"key":"1327_CR15","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000246316","volume":"192","author":"Kolde","year":"1996","unstructured":"Kolde G, Luger T, Sorg C, Sunderk\u00f6tter C (1996) Successful treatment of cutaneous leishmaniasis using interferon-gamma. Dermatology 192: 56\u201360","journal-title":"Dermatology"},{"key":"1327_CR16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1201-9712(03)90002-6","volume":"7","author":"Lee","year":"2003","unstructured":"Lee SA, Hasbun R (2003) Therapy of cutaneous leishmaniasis. Int J Infect Dis 7: 86\u201393","journal-title":"Int J Infect Dis"},{"key":"1327_CR17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diagmicrobio.2005.08.003","volume":"54","author":"Marques","year":"2006","unstructured":"Marques MJ, Volpini AC, Machado-Coelho GL et al. (2006) Comparison of polymerase chain reaction with other laboratory methods for the diagnosis of American cutaneous leishmaniasis: diagnosis of cutaneous leishmaniasis by polymerase chain reaction. Diagn Microbiol Infect Dis 54: 37\u201343","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1327_CR18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","volume":"326","author":"Martinez","year":"1992","unstructured":"Martinez S, Marr JJ (1992) Allopurinol in the treatment of American cutaneous leishmaniasis. N Engl J Med 326: 741\u2013744","journal-title":"N Engl J Med"},{"key":"1327_CR19","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/1523-1747.ep12381958","volume":"102","author":"Modlin","year":"1994","unstructured":"Modlin R (1994) Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 102: 828\u2013832","journal-title":"J Invest Dermatol"},{"key":"1327_CR20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1365-4632.2005.02628.x","volume":"44","author":"Panagiotopoulos","year":"2005","unstructured":"Panagiotopoulos A, Stavropoulos PG, Hasapi V et al. (2005) Treatment of cutaneous leishmaniasis with cryosurgery. Int J Dermatol 44: 749\u2013752","journal-title":"Int J Dermatol"},{"key":"1327_CR21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3201\/eid0906.030026","volume":"9","author":"Reithinger","year":"2003","unstructured":"Reithinger R, Mohsen M, Aadil K et al. (2003) Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. Emerg Infect Dis 9: 727\u2013729","journal-title":"Emerg Infect Dis"},{"key":"1327_CR22","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","volume":"40","author":"Reithinger","year":"2005","unstructured":"Reithinger R, Mohsen M, Wahid M et al. (2005) Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial. Clin Infect Dis 40: 1148\u20131155","journal-title":"Clin Infect Dis"},{"key":"1327_CR23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","volume":"2","author":"Sacks","year":"2002","unstructured":"Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2: 845\u2013858","journal-title":"Nat Rev Immunol"},{"key":"1327_CR24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(06)70492-3","volume":"6","author":"Schwartz","year":"2006","unstructured":"Schwartz E, Hatz C, Blum J (2006) New world cutaneous leishmaniasis in travellers. Lancet Infect Dis 6: 342\u2013392","journal-title":"Lancet Infect Dis"},{"key":"1327_CR25","doi-asserted-by":"crossref","unstructured":"Solomon M, Baum S, Barzilai A et al. (in press) Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis. J Am Acad Dermatol: Epub ahead of print","DOI":"10.1016\/j.jaad.2006.06.044"},{"key":"1327_CR26","unstructured":"Sunderk\u00f6tter C (im Druck) Hautinfektionen durch Parasiten. In: Marre R, Mertens T, Trautmann M, Zimmerli W (Hrsg) Klinische Infektiologie. 2. Aufl. Urban und Fischer, M\u00fcnchen"},{"key":"1327_CR27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.0019-2805.2004.01836.x","volume":"111","author":"Sunderk\u00f6tter","year":"2004","unstructured":"Sunderk\u00f6tter C, Tomimori-Yamashita J, Nix V et al. (2004). High Expression of MRP8 and MRP14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy. Immunology 111: 472\u2013480","journal-title":"Immunology"},{"key":"1327_CR28","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1086\/345772","volume":"186","author":"Turetz","year":"2002","unstructured":"Turetz ML, Machado PR, Ko AI et al. (2002) Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 186: 1829\u20131834","journal-title":"J Infect Dis"},{"key":"1327_CR29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0035-9203(01)90158-0","volume":"95","author":"Vardy","year":"2001","unstructured":"Vardy D, Barenholz Y, Naftoliev N et al. (2001) Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B. Trans R Soc Trop Med Hyg 95: 184\u2013186","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1327_CR30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-126-3-199702010-00010","volume":"126","author":"Velez","year":"1997","unstructured":"Velez I, Agudelo S, Hendrickx E et al. (1997) Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial. Ann Intern Med 126: 232\u2013236","journal-title":"Ann Intern Med"},{"key":"1327_CR31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0625.2007.00554.x","volume":"16","author":"Stebut","year":"2007","unstructured":"Stebut E von (2007) Cutaneous Leishmania infection: progress in pathogenesis research and experimental therapy. Exp Dermatol 16: 340\u2013346","journal-title":"Exp Dermatol"},{"key":"1327_CR32","first-page":"115","volume":"17","author":"Stebut","year":"2007","unstructured":"Stebut E von (2007) Immunology of cutaneous leishmaniasis: the role of mast cells, phagocytes and dendritic cells for protective immunity. Eur J Dermatol 17: 115\u2013122","journal-title":"Eur J Dermatol"},{"key":"1327_CR33","doi-asserted-by":"crossref","unstructured":"Woelbing F, Kostka SL, Moelle K et al. (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med. 203: 177\u2013188","DOI":"10.1084\/jem.20052288"},{"key":"1327_CR34","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1128\/IAI.67.10.5258-5264.1999","volume":"67","author":"Wolday","year":"1999","unstructured":"Wolday D, Akuffo H, Demissie A, Britton S (1999) Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Infect Immun 67: 5258\u20135264","journal-title":"Infect Immun"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-007-1327-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-007-1327-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-007-1327-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T12:52:29Z","timestamp":1587473549000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-007-1327-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1007\/s00105-007-1327-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}